118 related articles for article (PubMed ID: 38426797)
1. Bruceantinol targeting STAT3 exerts promising antitumor effects in in vitro and in vivo osteosarcoma models.
Miao J; Chen S; Cao H; Ding Z; Li Y; Wang W; Nundlall K; Deng Y; Li J
Mol Carcinog; 2024 Jun; 63(6):1133-1145. PubMed ID: 38426797
[TBL] [Abstract][Full Text] [Related]
2. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention.
He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
[TBL] [Abstract][Full Text] [Related]
3. Bruceantinol works as a CDK2/4/6 inhibitor to inhibit the growth of breast cancer cells.
Sun L; Wang Y; Li J; Xu S; Xu S; Li J
Chem Biol Interact; 2024 May; 395():110999. PubMed ID: 38608999
[TBL] [Abstract][Full Text] [Related]
4. Targeting colon cancer with the novel STAT3 inhibitor bruceantinol.
Wei N; Li J; Fang C; Chang J; Xirou V; Syrigos NK; Marks BJ; Chu E; Schmitz JC
Oncogene; 2019 Mar; 38(10):1676-1687. PubMed ID: 30348989
[TBL] [Abstract][Full Text] [Related]
5. Quassinoid analogs exert potent antitumor activity via reversible protein biosynthesis inhibition in human colorectal cancer.
Wei N; Burnett J; Crocker DL; Huang Y; Li S; Wipf P; Chu E; Schmitz JC
Biochem Pharmacol; 2023 Jun; 212():115564. PubMed ID: 37116665
[TBL] [Abstract][Full Text] [Related]
6. A Rapid and Sensitive UPLC-MS/MS Method for Quantification of Bruceantinol in Rat Plasma and Its Application to a Pharmacokinetic Study.
Li J; Zheng D; Zhen B; Sun Y; Chen F; Zhan K; Wei N; Zhang L
Planta Med; 2018 Jan; 84(2):111-116. PubMed ID: 28759935
[TBL] [Abstract][Full Text] [Related]
7. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
[TBL] [Abstract][Full Text] [Related]
8. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
[TBL] [Abstract][Full Text] [Related]
9. Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway.
Hu H; Wang S; Shi D; Zhong B; Huang X; Shi C; Shao Z
Onco Targets Ther; 2019; 12():5377-5388. PubMed ID: 31371981
[No Abstract] [Full Text] [Related]
10. Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway.
Wang S; Hu H; Zhong B; Shi D; Qing X; Cheng C; Deng X; Zhang Z; Shao Z
Cancer Med; 2019 Dec; 8(17):7345-7358. PubMed ID: 31631559
[TBL] [Abstract][Full Text] [Related]
11. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
Yan J; Wang Q; Zou K; Wang L; Schwartz EB; Fuchs JR; Zheng Z; Wu J
Mol Med Rep; 2015 Jul; 12(1):498-502. PubMed ID: 25760445
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.
Chen C; Zhang H; Yu Y; Huang Q; Wang W; Niu J; Lou J; Ren T; Huang Y; Guo W
Aging (Albany NY); 2021 Jun; 13(13):17901-17913. PubMed ID: 34170850
[TBL] [Abstract][Full Text] [Related]
14. T52 attenuates oncogenic STAT3 signaling and suppresses osteosarcoma.
Tian L; Li C; Xiang L; Zeng J; Chen S; Guo W; Chen S; Wang Y; He X; Su P; Xu C
Phytomedicine; 2023 Jun; 114():154799. PubMed ID: 37058945
[TBL] [Abstract][Full Text] [Related]
15. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A.
Wang Z; Wang C; Zuo D; Zhang T; Yin F; Zhou Z; Wang H; Xu J; Mao M; Wang G; Hua Y; Sun W; Cai Z
Int J Biol Sci; 2019; 15(3):668-679. PubMed ID: 30745853
[TBL] [Abstract][Full Text] [Related]
17. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
Mao M; Zhang T; Wang Z; Wang H; Xu J; Yin F; Wang G; Sun M; Wang Z; Hua Y; Cai Z
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1214-1225. PubMed ID: 30659925
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway.
Wang W; Li J; Ding Z; Li Y; Wang J; Chen S; Miao J
J Cell Mol Med; 2019 Sep; 23(9):6454-6465. PubMed ID: 31293090
[TBL] [Abstract][Full Text] [Related]
19. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z
Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119
[TBL] [Abstract][Full Text] [Related]
20. Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway.
Ma X; Xu W; Jin X; Mu H; Wang Z; Hua Y; Cai Z; Zhang T
Eur J Pharmacol; 2023 Mar; 942():175529. PubMed ID: 36690054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
